WEST PHARMACEUTICAL SERVICES, INC. (WST) Operating cash flow 2016–2025
WEST PHARMACEUTICAL SERVICES, INC. (WST) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$754.8MFY2025 · since FY2016: $219.4M → $754.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $754.8M | +15.5% |
| FY2024 | $653.4M | -15.9% |
| FY2023 | $776.5M | +7.3% |
| FY2022 | $724.0M | +24.0% |
| FY2021 | $584.0M | +23.6% |
| FY2020 | $472.5M | +28.7% |
| FY2019 | $367.2M | +27.2% |
| FY2018 | $288.6M | +9.6% |
| FY2017 | $263.3M | +20.0% |
| FY2016 | $219.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice